Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 1
2007 3
2008 3
2009 5
2010 5
2011 7
2012 8
2013 8
2014 5
2015 7
2016 15
2017 11
2018 11
2019 21
2020 16
2021 28
2022 9
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
[Cutaneous diphtheria].
Jochims F, Lippmann N, Simon JC. Jochims F, et al. Among authors: simon jc. Dermatologie (Heidelb). 2024 Apr;75(4):343. doi: 10.1007/s00105-024-05296-w. Dermatologie (Heidelb). 2024. PMID: 38277020 German. No abstract available.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
[Nahrungsmittelallergie - Neue Risiken durch vegane Ernährung? Überblick zu neuen Allergenquellen und aktuelle Daten zum Anaphylaxierisiko: Food allergy - New risks through vegan diet? Overview of new allergen sources and current data on the potential risk of anaphylaxis].
Präger L, Simon JC, Treudler R. Präger L, et al. Among authors: simon jc. J Dtsch Dermatol Ges. 2023 Nov;21(11):1308-1314. doi: 10.1111/ddg.15157_g. J Dtsch Dermatol Ges. 2023. PMID: 37946654 Review. German.
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.
Haist M, Stege H, Rogall F, Tan Y, von Wasielewski I, Klespe KC, Meier F, Mohr P, Kähler KC, Weichenthal M, Hauschild A, Schadendorf D, Ugurel S, Lodde G, Zimmer L, Gutzmer R, Debus D, Schilling B, Kreuter A, Ulrich J, Meiss F, Herbst R, Forschner A, Leiter U, Pfoehler C, Kaatz M, Ziller F, Hassel JC, Tronnier M, Sachse M, Dippel E, Terheyden P, Berking C, Heppt MV, Kiecker F, Haferkamp S, Gebhardt C, Simon JC, Grabbe S, Loquai C. Haist M, et al. Among authors: simon jc. J Immunother Cancer. 2023 Sep;11(9):e007630. doi: 10.1136/jitc-2023-007630. J Immunother Cancer. 2023. PMID: 37730278 Free PMC article.
[Großflächiger Lupus vulgaris durch Mycobacterium bovis].
Zarnowski J, Simon JC, Kunz M. Zarnowski J, et al. Among authors: simon jc. J Dtsch Dermatol Ges. 2023 Apr;21 Suppl 2:6-8. doi: 10.1111/ddg.15100_g. J Dtsch Dermatol Ges. 2023. PMID: 37099002 German. No abstract available.
[Entwicklungen und Perspektiven in der Allergologie].
Treudler R, Simon JC. Treudler R, et al. Among authors: simon jc. J Dtsch Dermatol Ges. 2023 Apr;21(4):399-404. doi: 10.1111/ddg.15034_g. J Dtsch Dermatol Ges. 2023. PMID: 37070519 Review. German.
Developments and perspectives in allergology.
Treudler R, Simon JC. Treudler R, et al. Among authors: simon jc. J Dtsch Dermatol Ges. 2023 Apr;21(4):399-403. doi: 10.1111/ddg.15034. J Dtsch Dermatol Ges. 2023. PMID: 37070510 Review.
158 results